Speaker Profile

Ph.D., Chief Science Officer & Head of Therapeutics, 23andMe
Biography

Dr. Scheller serves as chief science officer and head of the newly formed therapeutics group at 23andMe. In his role, Dr. Scheller built a dedicated research and development team that will use human genetic data as the starting point for identifying new therapies for both common and rare diseases. Previously, Dr. Scheller served as executive vice president of research and early development at Genentech. Dr. Scheller also served on the faculty of Stanford University as a professor in the Departments of Biological Sciences and Molecular and Cellular Physiology and was an investigator at the Howard Hughes Medical Institute of Stanford University Medical Center. In 2013, Dr. Scheller received the Albert Lasker Basic Medical Research Award for discoveries concerning the molecular machinery and regulatory mechanism that underlie the rapid release of neurotransmitters. Dr. Scheller holds a Ph.D. in Chemistry from the California Institute of Technology. He was a postdoctoral fellow at the California Institute of Technology and Columbia University.

Session Abstract – PMWC 2017 Silicon Valley

Session Synopsis: Genomic discovery has fueled major advances in medicine and drug discovery spanning rare diseases, cancer and broader precision medicine initiatives. Leaders of large-scale human genetics programs share their experiences and perspectives on the biggest successes, challenges and overall potential for the future of human genetics in transforming science to medicine.

Don't Miss Important Precision Medicine Updates

PMWC is the most comprehensive precision medicine conference. To receive the lastest news and updates from the field, subscribe to the newsletter here.

You have Successfully Subscribed!